The role of 11-oxygenated androgens in prostate cancer

por Snaterse, Gido, Hofland, Johannes, Lapauw, Bruno
Publicado 2023

What’s new on the HPA axis?

por Hofland, Johannes, Bakker, Jan, Feelders, Richard A.
Publicado 2015

Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms

por Hofland, Johannes, Kaltsas, Gregory, de Herder, Wouter W
Publicado 2020

New Directions in Imaging Neuroendocrine Neoplasms

por Refardt, Julie, Hofland, Johannes, Wild, Damian, Christ, Emanuel
Publicado 2021

Peptide Receptor Radionuclide Therapy

por Hofland, Johannes, Brabander, Tessa, Verburg, Frederik A, Feelders, Richard A, de Herder, Wouter W
Publicado 2022

SAT-LB002 Steroid Metabolome Analysis Reveals 11-Ketotestosterone as the Most Abundant Androgen in Castration-Resistant Prostate Cancer Patients on Second-Line Therapies

por Snaterse, Gido, van Dessel, Lisanne, Taylor, Angela, Visser, Jenny, Arlt, Wiebke, Lolkema, Martijn, Hofland, Johannes
Publicado 2019

A Clinical Guide to Peptide Receptor Radionuclide Therapy with (177)Lu-DOTATATE in Neuroendocrine Tumor Patients

por Becx, Morticia N., Minczeles, Noémie S., Brabander, Tessa, de Herder, Wouter W., Nonnekens, Julie, Hofland, Johannes
Publicado 2022

Peptide Receptor Radionuclide Therapy With (177)Lu-DOTATATE for Symptomatic Control of Refractory Carcinoid Syndrome

por Zandee, Wouter T, Brabander, Tessa, Blažević, Anela, Minczeles, Noémie S, Feelders, Richard A, de Herder, Wouter W, Hofland, Johannes
Publicado 2021

Treatment with somatostatin analogues and PRRT in metastatic middle ear adenoma with neuroendocrine features

por Lima Ferreira, Joana, Marques, Bernardo, Menke-van der Houven van Oordt, C Willemien, de Herder, Wouter W, Brabander, Tessa, Hofland, Johannes
Publicado 2021

Comparison of [(18)F]DOPA and [(68)Ga]DOTA-TOC as a PET imaging tracer before peptide receptor radionuclide therapy

por Veenstra, Emile B., Brouwers, Adrienne H., de Groot, Derk Jan A., Hofland, Johannes, Walenkamp, Annemiek M. E., Brabander, Tessa, Zandee, Wouter T., Noordzij, Walter
Publicado 2022

Evolution of the Mesenteric Mass in Small Intestinal Neuroendocrine Tumours

por Blažević, Anela, Brabander, Tessa, Zandee, Wouter T., Hofland, Johannes, Franssen, Gaston J. H., van Velthuysen, Marie-Louise F., Feelders, Richard A., De Herder, Wouter W.
Publicado 2021

Sexual Dimorphism in Small-intestinal Neuroendocrine Tumors: Lower Prevalence of Mesenteric Disease in Premenopausal Women

por Blažević, Anela, Iyer, Anand M, van Velthuysen, Marie-Louise F, Hofland, Johannes, Oudijk, Lindsey, de Herder, Wouter W, Hofland, Leo J, Feelders, Richard A
Publicado 2022

Synoptic reporting of echocardiography in carcinoid heart disease (ENETS Carcinoid Heart Disease Task Force)

por Hofland, Johannes, Lamarca, Angela, Steeds, Richard, Toumpanakis, Christos, Srirajaskanthan, Rajaventhan, Riechelmann, Rachel, Panzuto, Francesco, Frilling, Andrea, Denecke, Timm, Christ, Emanuel, Grozinsky‐Glasberg, Simona, Davar, Joseph
Publicado 2021

Effect of epigenetic treatment on SST(2) expression in neuroendocrine tumour patients

por Refardt, Julie, Klomp, Maria J., van Koetsveld, Peter M., Dogan, Fadime, Konijnenberg, Mark, Brabander, Tessa, Feelders, Richard A., de Herder, Wouter W., Hofland, Leo J., Hofland, Johannes
Publicado 2022

Abiraterone switches castration‐resistant prostate cancer dependency from adrenal androgens towards androgen receptor variants and glucocorticoid receptor signalling

por Moll, J. Matthijs, Hofland, Johannes, Teubel, Wilma J., de Ridder, Corina M. A., Taylor, Angela E., Graeser, Ralph, Arlt, Wiebke, Jenster, Guido W., van Weerden, Wytske M.
Publicado 2022

Fluorescence-guided surgery using methylene blue to improve identification of metastatic small intestinal neuroendocrine tumours

por Galema, Hidde A, van Ginhoven, Tessa M, Franssen, Gaston J H, Hofland, Johannes, Bouman, Claire G O T, Verhoef, Cornelis, Vahrmeijer, Alexander L, Hutteman, Merlijn, Hilling, Denise E, Keereweer, Stijn
Publicado 2023

Inflammatory markers and long term hematotoxicity of holmium-166-radioembolization in liver-dominant metastatic neuroendocrine tumors after initial peptide receptor radionuclide th...

por Ebbers, Sander C., Brabander, Tessa, Tesselaar, Margot E. T., Hofland, Johannes, Braat, Manon N. G. J. A., Wessels, Frank J., Barentsz, Maarten W., Lam, Marnix G. E. H., Braat, Arthur J. A. T.
Publicado 2022

11-Ketotestosterone is the predominant active androgen in prostate cancer patients after castration

por Snaterse, Gido, van Dessel, Lisanne F., van Riet, Job, Taylor, Angela E., van der Vlugt-Daane, Michelle, Hamberg, Paul, de Wit, Ronald, Visser, Jenny A., Arlt, Wiebke, Lolkema, Martijn P., Hofland, Johannes
Publicado 2021

European Neuroendocrine Tumor Society (ENETS) 2022 Guidance Paper for Carcinoid Syndrome and Carcinoid Heart Disease

por Grozinsky‐Glasberg, Simona, Davar, Joseph, Hofland, Johannes, Dobson, Rebecca, Prasad, Vikas, Pascher, Andreas, Denecke, Timm, Tesselaar, Margot E. T., Panzuto, Francesco, Albåge, Anders, Connolly, Heidi M., Obadia, Jean‐Francois, Riechelmann, Rachel, Toumpanakis, Christos
Publicado 2022

Epigenetic regulation of SST(2) expression in small intestinal neuroendocrine tumors

por Klomp, Maria J., Refardt, Julie, van Koetsveld, Peter M., Campana, Claudia, Dalm, Simone U., Dogan, Fadime, van Velthuysen, Marie-Louise F., Feelders, Richard A., de Herder, Wouter W., Hofland, Johannes, Hofland, Leo J.
Publicado 2023